Standard Dosing Regimens

The British Journal of Dermatology recommends 25-50 mg of hydroxyzine at bedtime when added to a non-sedating antihistamine during the day, to help patients sleep better while minimizing daytime sedation and performance impairment 1, 2

Clinical Approach Algorithm

The British Journal of Dermatology suggests using cetirizine 10 mg daily, fexofenadine 180 mg daily, or loratadine 10 mg daily as first-line therapy, providing effective antipruritic effects without significant sedation 3, 4, 1
If pruritus persists after 2-3 days, the British Journal of Dermatology recommends adding hydroxyzine 25-50 mg at bedtime to the non-sedating antihistamine 1, 2

The British Journal of Dermatology advises reducing the dose by 50% in moderate renal impairment (creatinine clearance 10-20 mL/min) 1, 2, 5
The British Journal of Dermatology recommends avoiding hydroxyzine completely in severe renal impairment (creatinine clearance <10 mL/min) 1
The British Journal of Dermatology suggests avoiding hydroxyzine in severe liver disease due to enhanced sedative effects 2, 5
The British Journal of Dermatology advises using lower doses in elderly patients due to increased risk of sedation, anticholinergic effects, and cognitive impairment 2
The British Journal of Dermatology recommends considering avoiding sedating antihistamines entirely in elderly patients with pruritus 6

The British Journal of Dermatology notes that hydroxyzine causes 80% sedation rates compared to 50% with diphenhydramine, and significantly prolongs simple and choice reaction times at 25 mg twice daily dosing 2
The British Journal of Dermatology warns that hydroxyzine is contraindicated in early pregnancy per UK manufacturer guidelines 2, 5
The British Journal of Dermatology advises avoiding hydroxyzine with other CNS depressants due to enhanced sedation 2
The British Journal of Dermatology recommends not using hydroxyzine for prolonged monotherapy due to performance concerns 1, 2
The British Journal of Dermatology suggests using caution in patients with prostatic hypertrophy, elevated intraocular pressure, or cognitive impairment due to anticholinergic effects 2

For generalized pruritus of unknown origin, guidelines recommend considering non-sedative antihistamines such as fexofenadine 180 mg during the day, while sedative antihistamines like hydroxyzine are recommended only in the short-term or palliative setting, as suggested by the British Journal of Dermatology guidelines 7
The American Academy of Allergy, Asthma, and Immunology recommends the use of H1 receptor blockers like fexofenadine at 2-4 times FDA-approved doses for mast cell activation syndrome (MCAS), and first-generation H1 antihistamines including hydroxyzine can be added for additional symptom control, though their sedation and cognitive effects are concerning, particularly in elderly patients 8

Elderly patients require extra caution with hydroxyzine due to increased risk of sedation, anticholinergic effects, and cognitive impairment, and some guidelines suggest avoiding sedating antihistamines entirely in elderly patients with pruritus, as recommended by the Journal of Allergy and Clinical Immunology 8

If the combination is needed but poorly tolerated, consider H1 and H2 antagonist combinations (fexofenadine plus cimetidine or famotidine) or up-dosing fexofenadine to 2-4 times the standard dose before adding sedating antihistamines, as suggested by the British Journal of Dermatology and the Journal of Allergy and Clinical Immunology 7, 8